People: Gilead Sciences Inc (GILD.O)

GILD.O on Nasdaq

114.22USD
30 Oct 2014
Price Change (% chg)

$3.50 (+3.16%)
Prev Close
$110.72
Open
$110.72
Day's High
$114.35
Day's Low
$110.60
Volume
13,796,740
Avg. Vol
14,475,986
52-wk High
$114.35
52-wk Low
$63.50

Search Stocks

Alton, Gregg 

Brief Biography

Mr. Gregg H. Alton is Executive Vice President - Corporate and Medical Affairs of Gilead Sciences Inc. Mr. Alton joined the company in 1999, and served as General Counsel from 2000 to 2009. In his current role, Mr. Alton is responsible for legal affairs, corporate compliance and quality, government affairs, medical affairs, public affairs and international access activities. Prior to joining the company , Mr. Alton was an attorney at the law firm of Cooley Godward Kronish LLP, where he specialized in mergers and acquisitions, corporate partnerships and corporate finance transactions for healthcare and information technology companies. Mr. Alton is a member of the board of the AIDS Healthcare Foundation, a member of the board of Oculus Innovative Sciences, Inc. and a member of the board of BayBio, a San Francisco Bay Area life sciences industry organization. He received his B.A. in Legal Studies from the University of California at Berkeley and his J.D. from Stanford University.

Basic Compensation

Total Annual Compensation, USD Long-Term Incentive Plans, USD All Other, USD Fiscal Year Total, USD
1,237,840 -- 1,278,690 4,035,530

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 121,025 3,274,660.00
Name Fiscal Year Total

John Martin

15,451,900

John Milligan

6,566,290

Robin Washington

3,941,730

Norbert Bischofberger

5,588,390

Gregg Alton

4,035,530

Paul Carter

--
As Of 30 Dec 2013
Search Stocks